Anzeige
Mehr »
Mittwoch, 08.10.2025 - Börsentäglich über 12.000 News
Golden Cross könnte Australiens nächste Goldentdeckung in der Pipeline haben!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JQ1X | ISIN: CA0717341071 | Ticker-Symbol: BVF
Tradegate
07.10.25 | 16:31
5,500 Euro
+0,18 % +0,010
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BAUSCH HEALTH COMPANIES INC Chart 1 Jahr
5-Tage-Chart
BAUSCH HEALTH COMPANIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,4535,56207:56
5,4535,56207:50

Aktuelle News zur BAUSCH HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.09.Bausch Health Companies Inc: Bausch Health to release Q3 2025 results Oct. 291
30.09.Stocks in Play: Bausch Health Companies Inc.-
30.09.Bausch Health Companies Inc.: Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV220The Balancing Act airing on Lifetime will showcase how innovative treatments Thermage® FLX, Clear + Brilliant®, and Fraxel FTX offer energy-based treatment options that help maintain a youthful appearance...
► Artikel lesen
30.09.Bausch Health Companies Inc.: Bausch Health to Announce Third Quarter 2025 Results on October 29152LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025....
► Artikel lesen
BAUSCH HEALTH Aktie jetzt für 0€ handeln
29.09.Bausch Health Companies Inc: Bausch Health's OraPharma rolls out dentistry podcast1
29.09.Bausch Health Companies Inc.: Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry260Designed for dental professionals, OraTalks connects leading voices with insights to spark meaningful dialogue.Nine-episode inaugural season hosted by industry thought leader Melissa K. Turner, BASDH...
► Artikel lesen
12.09.Bausch Health Companies Inc: Bausch Health completes tender offer to acquire Durect23
12.09.Bausch Health Completes $63 Mln Acquisition Of DURECT, Adds Breakthrough AH Therapy5
11.09.Bausch Health Companies Acquires Durect Corporation11
11.09.Bausch Health Companies Inc. - 8-K, Current Report1
11.09.Bausch Health Companies Inc.: Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio477The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health's hepatology pipeline LAVAL...
► Artikel lesen
05.09.Bausch Health Companies Inc.: Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage Non-Surgical System270LAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aesthetics...
► Artikel lesen
05.09.Bausch Health's Thermage technology surpasses 5 million treatments7
26.08.Bausch Health Companies Inc: Bausch Health extends Durect tender offer to Sept. 104
26.08.Bausch Health Companies Inc.: Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025298LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX)...
► Artikel lesen
21.08.Bausch Health Companies Inc: Bausch's Cabtreo acne drug on two provincial drug plans3
21.08.Bausch Health Companies Inc.: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, CABTREO, Now Available Through Public Drug Plans of Quebec and Saskatchewan307LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced that...
► Artikel lesen
21.08.Bausch Health: Umsatzwachstum in Q2 2025, Aktie bricht trotz Gewinnüberraschung ein31
20.08.A Look Into Bausch Health Companies Inc's Price Over Earnings2
18.08.Bausch Health (BHC) Climbs 45% on Insider Buying3
Weiter >>
134 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,13